{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T12:24:05Z","timestamp":1759667045191},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T00:00:00Z","timestamp":1504051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T00:00:00Z","timestamp":1504051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study aimed to determine whether a serological response could predict the normalization of cerebrospinal fluid (CSF) abnormalities at 6 months after treatment in human immunodeficiency virus (HIV)-negative neurosyphilis patients. A total of 123 neurosyphilis patients were recruited at baseline, 58 of these patients undergoing treatment, repeated CSF examinations and serological tests for syphilis at 6 months after treatment were included in the follow-up study. Before treatment, the CSF rapid plasma reagin (RPR) titer, CSF <jats:italic>Treponema pallidum<\/jats:italic> particle agglutination (TPPA) titer, CSF leukocyte count, and CSF protein concentration were correlated with both serum RPR and TPPA titers. At 6 months after treatment, 28 and nine patients achieved serological responses of RPR and TPPA tests, respectively. The sensitivities of the serological response of RPR and TPPA tests for identifying the normalization of CSF abnormalities were 60.0\u223c83.3% and 17.1~22.2%, respectively; and 75.0\u223c91.3% of patients showing serological response of RPR test also achieved CSF normalization, suggesting that the serological response could predict CSF normalization to some degree. Particularly, in patients with \u22658-fold decreases in the serum RPR titer, the CSF RPR, CSF leukocyte count, and CSF protein concentration had normalized, and follow-up lumbar puncture could be reduced considering the resolution of neurological symptoms.<\/jats:p>","DOI":"10.1038\/s41598-017-10387-x","type":"journal-article","created":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T07:37:23Z","timestamp":1503560243000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Serological Response Predicts Normalization of Cerebrospinal Fluid Abnormalities at Six Months after Treatment in HIV-Negative Neurosyphilis Patients"],"prefix":"10.1038","volume":"7","author":[{"given":"Yao","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man-Li","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Rong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Hong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Lian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Ling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian-Ci","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Jun","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,30]]},"reference":[{"key":"10387_CR1","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1086\/381227","volume":"189","author":"CM Marra","year":"2004","unstructured":"Marra, C. M. et al. Cerebrospinal fluid abnormalities in patients with syphilis: Association with clinical and laboratory features. J Infect Dis \n                           189, 369\u2013376 (2004).","journal-title":"J Infect Dis"},{"key":"10387_CR2","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/jdv.13514","volume":"30","author":"M Shi","year":"2015","unstructured":"Shi, M. et al. Risk profiles of neurosyphilis in HIV-negative patients with primary, secondary and latent syphilis: Implications for clinical intervention. J Eur Acad Dermatol Venereol \n                           30, 659\u2013666 (2015).","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10387_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6404a1","volume":"64","author":"KA Workowski","year":"2015","unstructured":"Workowski, K. A. & Bolan, G. A. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep \n                           64, 1\u2013137 (2015).","journal-title":"MMWR Recomm Rep"},{"key":"10387_CR4","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1086\/591534","volume":"47","author":"CM Marra","year":"2008","unstructured":"Marra, C. M., Maxwell, C. L., Tantalo, L. C., Sahi, S. K. & Lukehart, S. A. Normalization of serum rapid plasma reagin titer predicts normalization of cerebrospinal fluid and clinical abnormalities after treatment of neurosyphilis. Clin Infect Dis \n                           47, 893\u2013899 (2008).","journal-title":"Clin Infect Dis"},{"key":"10387_CR5","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1093\/cid\/cis757","volume":"55","author":"DF Knaute","year":"2012","unstructured":"Knaute, D. F., Graf, N., Lautenschlager, S., Weber, R. & Bosshard, P. P. Serological response to treatment of syphilis according to disease stage and HIV status. Clin Infect Dis \n                           55, 1615\u20131622 (2012).","journal-title":"Clin Infect Dis"},{"key":"10387_CR6","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1111\/jdv.12734","volume":"28","author":"M Janier","year":"2014","unstructured":"Janier, M. et al. European guideline on the management of syphilis. J Eur Acad Dermatol Venereol \n                           28, 1581\u20131593 (2014).","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10387_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2339-3","volume":"17","author":"Y Xiao","year":"2017","unstructured":"Xiao, Y. et al. Novel predictors of neurosyphilis among HIV-negative syphilis patients with neurological symptoms: An observational study. BMC Infect Dis \n                           17, 310 (2017).","journal-title":"BMC Infect Dis"},{"key":"10387_CR8","first-page":"1714","volume":"21","author":"CM Marra","year":"2015","unstructured":"Marra, C. M. Neurosyphilis. Continuum (Minneap Minn) \n                           21, 1714\u20131728 (2015).","journal-title":"Continuum (Minneap Minn)"},{"key":"10387_CR9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.diagmicrobio.2011.07.005","volume":"71","author":"LR Lin","year":"2011","unstructured":"Lin, L. R. et al. Further evaluation of the characteristics of Treponema pallidum-specific IgM antibody in syphilis serofast reaction patients. Diagn Microbiol Infect Dis \n                           71, 201\u2013207 (2011).","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10387_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.8.1.1","volume":"8","author":"SA Larsen","year":"1995","unstructured":"Larsen, S. A., Steiner, B. M. & Rudolph, A. H. Laboratory diagnosis and interpretation of tests for syphilis. Clin Microbiol Rev \n                           8, 1\u201321 (1995).","journal-title":"Clin Microbiol Rev"},{"key":"10387_CR11","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1086\/382532","volume":"38","author":"CM Marra","year":"2004","unstructured":"Marra, C. M. et al. Normalization of cerebrospinal fluid abnormalities after neurosyphilis therapy: Does HIV status matter? Clin Infect Dis \n                           38, 1001\u20131006 (2004).","journal-title":"Clin Infect Dis"},{"key":"10387_CR12","unstructured":"Centers for Disease Control and Prevention. STD surveillance case definitions. Centers for Disease Control and Prevention. http:\/\/www.cdc.gov\/std\/stats\/CaseDefinitions-2014.pdf (2014)."},{"key":"10387_CR13","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1258\/ijsa.2008.008510","volume":"20","author":"P French","year":"2009","unstructured":"French, P. et al. IUSTI: 2008 European Guidelines on the Management of Syphilis. Int J STD AIDS \n                           20, 300\u2013309 (2009).","journal-title":"Int J STD AIDS"},{"key":"10387_CR14","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.intimp.2013.10.008","volume":"17","author":"LL Liu","year":"2013","unstructured":"Liu, L. L. et al. Assessing cerebrospinal fluid abnormalities in neurosyphilis patients without human immunodeficiency virus infection. Int Immunopharmacol \n                           17, 1120\u20131124 (2013).","journal-title":"Int Immunopharmacol"},{"key":"10387_CR15","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1017\/S0950268815002344","volume":"144","author":"Y Xiao","year":"2016","unstructured":"Xiao, Y. et al. Factors associated with syphilis infection: A comprehensive analysis based on a case-control study. Epidemiol Infect \n                           144, 1165\u20131174 (2016).","journal-title":"Epidemiol Infect"},{"key":"10387_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.intimp.2014.03.011","volume":"20","author":"F Liu","year":"2014","unstructured":"Liu, F. et al. Characterization of the classical biological false-positive reaction in the serological test for syphilis in the modern era. Int Immunopharmacol \n                           20, 331\u2013336 (2014).","journal-title":"Int Immunopharmacol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10387-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10387-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10387-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T09:41:22Z","timestamp":1671788482000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10387-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,30]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["10387"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-10387-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,30]]},"assertion":[{"value":"9 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"9911"}}